L-ELISA of the intraleukin-1 beta monkey (Mk IL-1β) quantifies Mk IL-1β in serum, plasma or cell culture medium of the monkey. The dosage will recognize only l-l-l-l-β of natural and recombinant monkeys. Method principle...
Accession number
P48090,P79182
Dose range
3.9-250 pg/ml
Sensitivity of the dosage
0.3 pg/ml
Conjugate
Biotin
Product type
Kit ELISA
Brand
Invitrogen
L-ELISA of the intraleukin-1 beta monkey (Mk IL-1β) quantifies Mk IL-1β in serum, plasma or cell culture medium of the monkey. The dosage will recognize only l-l-l-l-β of natural and recombinant monkeys. Method principle...
L-ELISA of the intraleukin-1 beta monkey (Mk IL-1β) quantifies Mk IL-1β in serum, plasma or cell culture medium of the monkey. The dosage will recognize only l-l-l-l-β of natural and recombinant monkeys. Principle of the L-ELISA solid phase sandwich of l-L1β in monkeys (an immuno-enzymatic test) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-vested in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bound to immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
The beta-interleukin-1 (IL-1 beta) is a proinflammatory cytokine expressed by monocytes, macrophages, and dendritic cells. IL-1 beta is synthesized in response to inflammatory stimuli as a 31 kDa inactive proform that accumulates in cytosol. The cleavage of pro-IL-1 beta in the active 17 kDa protein requires the activation of inflammasomas, which are multiprotein complexes that respond to pathogens, stress conditions and other hazard signals. Activation of the inflammasoma triggers the treatment of the precursor of caspase-1 in its active form, which in turn cleaves the pro-IL-1 beta. IL-1 beta does not have a signal sequence peptide for the conventional ER/Golgi pathway and is secreted along the caspase-1 via an alternative mechanism and understood incompletely. Although the beta-IL-1 is most often secreted as active, the secretion of the uncleavened protein can be detectable under certain biological conditions. The signals of the IL-1 beta through two receptors, IL-1RI and IL-1RII, both of which are shared with the IL-1 alpha. The activity of the IL-1 beta may be moderated by the IL-1 receptor antagonist (IL-1RA), a protein produced by many types of cells that blocks receptor binding by competitive inhibition. IL-1 beta plays an important role in defending the innate host by triggering the production of other proinflammatory cytokines in target cells and by triggering acute phase responses to infection and injury. High levels of d的IL-1 beta have been associated with many chronic inflammatory conditions of the beta-IL-1 neutralizing the potential therapeutic value of antibodies.
Sensitivity
Sensitivity of the dosage: 0.3 pg/ml.
Measurement range
Dose range: 3.9-250 pg/ml.
Duration of dosing
Total duration of dosing: 3 h 10 min.
Reproducibility
Coefficient of variation within dose 5.1%, interdose 8.6%.